September 8 Completion of the acquisition of Yourgene Health plc and appointments of members of the board of directors
The acquisition strengthens capabilities and diversifies the diagnostics business globally, offering a complementary range of genomic technologies and services.
Paris, France and Eastleigh, United Kingdom – September 8, 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the completion of the acquisition by Novacyt UK Holdings Limited (“Novacyt UK”), a wholly owned subsidiary of Novacyt, from the entire share capital of Yourgene Health plc (“Yourgene”), an international molecular diagnostics group (“the Acquisition”). The Acquisition was completed pursuant to a plan of arrangement between Yourgene and its shareholders under Part 26 of the UK Companies Act 2006 (the “Scheme”).
Novacyt SA published this content on September 8, 2023 and is solely responsible for the information contained therein. Distributed by Audienceunedited and unmodified, on September 8, 2023 at 11:14:08 UTC.
“Total social media fan. Travel maven. Evil coffee nerd. Extreme zombie specialist. Wannabe baconaholic. Organizer.”